Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $32.45 (-10.1%) * Over Last 12-Mos
Rating Score: 2.5 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
12/19/2014 Wells Fargo New Coverage Market Perform
(N/A)
36.00
(N/A)
35.57 36.12 1.55% Details
11/10/2014 Morgan Stanley New Coverage Underweight
(N/A)
25.00
(N/A)
34.89 36.12 3.53% Details
Like MYGN Ratings? Also take a look at TSRO, AZN, ABBV

MYGN Ratings News